Predictive performance of [18F]F-fibroblast activation protein inhibitor (FAPI)-42 positron emission tomography/computed tomography (PET/CT) in evaluating response of recurrent or metastatic gastrointestinal stromal tumors: complementary or alternative to [18F]fluorodeoxyglucose (FDG) PET/CT?

ABSTRACT:

SUBMITTER: Wu C 

PROVIDER: S-EPMC11320500 | biostudies-literature | 2024 Jun

REPOSITORIES: biostudies-literature